The workshop BAYES2013 will be held in Erasmus University Rotterdam (http://www.eur.nl/english/) on May 21-23, 2013.
Until recently the practical implementation of Bayesian thinking into pharmaceutical research has been slow due to either important computational challenge, lack of Bayesian education in the bio-statistical community or reluctance of regulatory authorities on the usefulness of the approach. However, recent developments within the preclinical setting and in the Model Based Drug Development paradigm indicate the rising interest and added value of Bayesian applications.
The objective of the workshop is multifold: The presentation of some applied case studies in the clinical, non-clinical and CMC setting should learn the participants in a first step about some success stories of the Bayesian thinking. This should propagate the Bayesian thinking and practices within the pharmaceutical industry. But more importantly, it emphasizes the advantages of Bayesian modeling for science and business as well as to offer opportunities for statisticians for reorientation within the changing environment of the (bio)pharmaceutical world.